J Clin Endocrinol Metab 75: 571, 1992 238 Yokoyama Y, Nakamura T, Nakamura R et al: Identification of activins and follistatin proteins in human follicular fluid and placenta
DISCLAIMER: This tool is intended for informational purposes only, and should not be interpreted as specific medical advice
Medical distributors, stockists, wholesalers, and pharma professionals interested in this nutraceutical softgel can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, bulk orders, pricing details, and distribution support services.
This article is an educational review of published research and is not medical advice
Weight loss : Retatrutide showed 28.7% at 68 weeks (Phase 3 TRIUMPH-4) versus survodutide's 18.7% at 46 weeks (Phase 2), though cross-trial comparisons are inherently limited